Ganciclovir and the treatment of Epstein-Barr virus hepatitis

L.A. Adams, B. Deboer, Bastiaan De Boer, Gary Jeffrey, R. Marley, G. Garas

    Research output: Contribution to journalReview article

    33 Citations (Scopus)

    Abstract

    Epstein-Barr virus (EBV) is part of the herpesvirus family that infects up to 90% of the population. Initial infection is often subclincal in children but will generally result in symptomatic infectious mononucleosis in adolescents and adults. Ganciclovir has been utilized in immunocompromised patients with EBV encephalitis and post-liver transplant for EBV fulminant hepatitis. Herein, the successful use of ganciclovir in two immunocompetent patients with severe EBV hepatitis is reported.
    Original languageEnglish
    Pages (from-to)1758-1760
    JournalGastroenterology & Hepatology
    Volume21
    DOIs
    Publication statusPublished - 2006

    Fingerprint Dive into the research topics of 'Ganciclovir and the treatment of Epstein-Barr virus hepatitis'. Together they form a unique fingerprint.

    Cite this